CVS Health (CVS) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some ...

CVS Health’s (NYSE: CVS) latest results affirm several points: their sales and adjusted profits remain stable, and they are adjusting their forecasts upward. Nonetheless, the quality of their profits ...

Get the live share price of CVS Health Corp (CVS), including intraday charts, historical performance, key financials, and market updates. Track the latest US stock market activity.

CVS Health ( ($CVS) ) has provided an update. On December 9, 2025, CVS Health held its 2025 Investor Day, where it updated its financial guidance ...

CVS Health CVS is scheduled to report third-quarter 2025 results on Oct. 29, before the market opens. The Zacks Consensus Estimate for third-quarter earnings per share (EPS) suggests a 24.8% increase ...

CVS is a strong buy now, with rising earnings, solid dividends, and steady growth prospects despite industry challenges. Read here for more analysis.

CVS Health raises its 2025 revenue outlook as Bank of America highlights stronger margins, new tech investments, and momentum behind the company's upcoming unified app.

CVS Health Corporation (NYSE:CVS) is one of the best blue-chip stocks to buy now. On November 3, 2025, TD Cowen lifted its price target on the stock to $100 from $99, while keeping a Buy rating. The ...

CVS Health Corporation is rated a Buy with a strong turnaround driving industry-leading results. Learn more about CVS stock here.

On Thursday, the Centers for Medicare & Medicaid Services (“CMS”) released the 2026 Star Ratings for Medicare Advantage Prescription Drug (“MAPD”) plans. The five-star rating system evaluates Medicare ...